Citigroup’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-15,217
| Closed | -$78K | – | 5292 |
|
|
2019
Q2 | $78K | Buy |
15,217
+1,946
| +15% | +$9.98K | ﹤0.01% | 3794 |
|
|
2019
Q1 | $48K | Buy |
13,271
+1,145
| +9% | +$4.14K | ﹤0.01% | 4059 |
|
|
2018
Q4 | $74K | Buy |
12,126
+53
| +0.4% | +$323 | ﹤0.01% | 3682 |
|
|
2018
Q3 | $70K | Buy |
12,073
+11,173
| +1,241% | +$64.8K | ﹤0.01% | 3849 |
|
|
2018
Q2 | $4K | Sell |
900
-5,398
| -86% | -$24K | ﹤0.01% | 4797 |
|
|
2018
Q1 | $27K | Buy |
6,298
+5,045
| +403% | +$21.6K | ﹤0.01% | 4087 |
|
|
2017
Q4 | $7K | Sell |
1,253
-1,050
| -46% | -$5.87K | ﹤0.01% | 4606 |
|
|
2017
Q3 | $14K | Buy |
2,303
+1,301
| +130% | +$7.91K | ﹤0.01% | 4138 |
|
|
2017
Q2 | $7K | Sell |
1,002
-6,069
| -86% | -$42.4K | ﹤0.01% | 4257 |
|
|
2017
Q1 | $37K | Sell |
7,071
-38,186
| -84% | -$200K | ﹤0.01% | 3814 |
|
|
2016
Q4 | $325K | Buy |
45,257
+28,996
| +178% | +$208K | ﹤0.01% | 3237 |
|
|
2016
Q3 | $152K | Buy |
16,261
+9,624
| +145% | +$90K | ﹤0.01% | 3162 |
|
|
2016
Q2 | $42K | Sell |
6,637
-24,444
| -79% | -$155K | ﹤0.01% | 3784 |
|
|
2016
Q1 | $172K | Buy |
31,081
+22,677
| +270% | +$125K | ﹤0.01% | 3600 |
|
|
2015
Q4 | $48K | Buy |
8,404
+6,308
| +301% | +$36K | ﹤0.01% | 4101 |
|
|
2015
Q3 | $18K | Sell |
2,096
-2,532
| -55% | -$21.7K | ﹤0.01% | 4128 |
|
|
2015
Q2 | $70K | Sell |
4,628
-1,589
| -26% | -$24K | ﹤0.01% | 3505 |
|
|
2015
Q1 | $100K | Sell |
6,217
-6,120
| -50% | -$98.4K | ﹤0.01% | 3403 |
|
|
2014
Q4 | $220K | Buy |
12,337
+10,775
| +690% | +$192K | ﹤0.01% | 3083 |
|
|
2014
Q3 | $16K | Buy |
1,562
+1,356
| +658% | +$13.9K | ﹤0.01% | 4398 |
|
|
2014
Q2 | $3K | Sell |
206
-1,252
| -86% | -$18.2K | ﹤0.01% | 5040 |
|
|
2014
Q1 | $27K | Sell |
1,458
-692
| -32% | -$12.8K | ﹤0.01% | 4341 |
|
|
2013
Q4 | $41K | Buy |
+2,150
| New | +$41K | ﹤0.01% | 4250 |
|